Philip Redpath
16Patents
4h-index
12Co-inventors
53Inventor score
Filing activity: Jul 24, 2014 → Aug 24, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9975915B1 | Crystalline forms of nicotinoyl ribosides, modified derivatives thereof, and phosphorylated analogs thereof, and methods of preparation thereof | Chemistry; Metallurgy | 18 | Active |
| US10000519B2 | Methods of preparing nicotinamide riboside and derivatives thereof | Emerging Cross-Sectional Technologies | 17 | Active |
| US10000520B2 | B-vitamin and amino acid conjugates ofnicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof | Chemistry; Metallurgy | 6 | Active |
| US10689411B2 | Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof | Chemistry; Metallurgy | 4 | Active |
| US10934322B2 | B-vitamin and amino acid conjugates of nicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof | Chemistry; Metallurgy | 4 | Active |
| US11242364B1 | Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof | Chemistry; Metallurgy | 3 | Active |
| US11274117B2 | Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof | Chemistry; Metallurgy | 3 | Active |
| US10815262B2 | Methods of preparing nicotinamide riboside and derivatives thereof | Emerging Cross-Sectional Technologies | 2 | Active |
| US10280190B2 | Nicotinic acid riboside or nicotinamide riboside compositions, reduced derivatives thereof, and the use thereof to enhance skin permeation in treating skin conditions | Human Necessities | 2 | Active |
| US11584770B2 | Methods of preparing nicotinamide riboside and derivatives thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US11981698B2 | Methods of preparing reduced nicotinamide riboside and derivatives thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11345720B2 | Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof | Chemistry; Metallurgy | 0 | Active |
| US12195494B2 | Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof | Chemistry; Metallurgy | 0 | Active |
| US11746123B2 | Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof | Chemistry; Metallurgy | 0 | Active |
| US12252506B2 | Methods of preparing nicotinamide riboside and derivatives thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11214589B2 | Crystalline forms of nicotinoyl ribosides and derivatives thereof, and methods of preparation thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.